Biomarin Pharmaceutical
Price & Volume
Stats
See more52W Range | $50.76-$73.51 |
Market Cap | $10.6B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $3B |
Revenue Growth (YoY) | 4.1% |
Gross Profit (12 Mos) | $2.5B |
Diluted EPS | $2.69 |
News
See moreYahoo Finance • 4 days ago
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know
Yahoo Finance • 20 days ago
Here Are Thursday’s Top Wall Street Analysts Research Calls: Amazon.com, Biogen, Caterpillar, e.l.f. Beauty, Southern Company and More
Yahoo Finance • 29 days ago
Why is BioMarin Pharmaceutical (BMRN) One of the Most Profitable Biotech Stocks to Buy?
About
CEO | Mr. Alexander Hardy |
CFO | Mr. Brian R. Mueller CPA |
Address | 770 Lindaro Street, San Rafael, CA, United States, 94901 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3,040 |
